Categories: Post

Biomedical Research

At no other time in history have we been this close to translating basic scientific discoveries into novel therapeutic strategies to benefit humankind. However, the traditional missions of academic institutions and the pharmaceutical industry are almost diametrically opposed. Have we reached the point where ‘publish or perish’ is being replaced by ‘patent and prosper’? Participants had a timely discussion with Dr. Mary Hendrix, President and Scientific Director, Children’s Memorial Research, about the role of industry competitiveness in biomedical research and its impact on the future of health care.

c2st

Recent Posts

Bridging Language and the Brain: An Interview with Keith Johnson, Ph.D.

Keith Johnson, Ph.D., Professor of Linguistics at the University of California, Berkeley, studies how language…

7 days ago

Under the Sea: The Invisible Changes to Ocean Life

At a long-term monitoring site at Tatoosh Island in northern Washington, researchers noticed an unexpected…

4 weeks ago

Synthetic Biology as a Tool to Advance Human Health: An Interview with an Expert

I remember sitting down a few years ago to write what was the most important…

1 month ago

GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution

In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as…

1 month ago

Vaccines: No Risk, No Reward

Vaccines are tools of modern medicine used in keeping us safe and healthy from the…

2 months ago

The Secret Psychology of Smiles

Did you know your smile is one of the most powerful social signals you have?…

2 months ago